Oxygen-containing fused tricyclic derivative, and preparation method therefor and use thereof

HK40137474APending Publication Date: 2026-09-11TUOJIE BIOTECH (SHANGHAI) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026126308
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-12-08
Filing Date
2026-07-17
Publication Date
2026-09-11
Patent Text Reader

Abstract

The invention provides an oxygen-containing fused tricyclic derivative as well as a preparation method and application thereof. Specifically, provided is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound shown in the formula (I) can be used as a cyclin-dependent kinase inhibitor and is used for preventing and / or treating diseases related to cyclin-dependent kinase. The definition of each substituent group in the formula (I) is described in the specification.
Need to check novelty before this filing date? Find Prior Art

Description

(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480040800.8 (22) Application Date 2024.07.26 (66) Domestic Priority Data 202310930530.5 2023.07.27 CN 202311681118.0 2023.12.08 CN (85) PCT International Application Entering National Phase Date 2025.12.18 (86) PCT International Application Application Data PCT / CN2024 / 107786 2024.07.26 (87) PCT International Application Publication Data WO2025 / 021189 ZH 2025.01.30 (71) Applicant Shanghai Tuojie Biomedical Technology Co., Ltd. Address 201203 Room 103, Building 14, No. 3728 Jinke Road, Shanghai Pudong New Area Free Trade Zone (72) Inventors: Li Yunfei, Liu Haomiao, Tan Liang, Li Jian (74) Patent Agency: Beijing Gecheng Intellectual Property Agency Co., Ltd. 11314 Patent Attorney: Cheng Wei (51) Int.Cl. C07D 498 / 06 (2006.01) A61P 35 / 00 (2006.01) A61K 31 / 5383 (2006.01) (54) Invention Title: An Oxygen-Containing Fused Tricyclic Derivative and Its Preparation Method and Use (57) Abstract: An oxygen-containing fused tricyclic derivative and its preparation method and use are provided. Specifically, a compound of formula (I) or a pharmaceutically usable salt thereof is provided. The compound of formula (I) can be used as a cyclin-dependent kinase inhibitor for the prevention and / or treatment of diseases related to cyclin-dependent kinase. The substituents in formula (I) are defined as described in the specification. CN 121399137 A 2026.01.23 CN 1 21 39 91 37 A